Cronos Group Inc (CRON)
2.59
+0.09
(+3.60%)
USD |
NASDAQ |
May 31, 16:00
2.585
0.00 (0.00%)
After-Hours: 20:00
Cronos Group Enterprise Value: 130.72M for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 31, 2024 | 130.72M |
May 30, 2024 | 96.33M |
May 29, 2024 | 119.25M |
May 28, 2024 | 165.10M |
May 24, 2024 | 149.82M |
May 23, 2024 | 149.82M |
May 22, 2024 | 207.12M |
May 21, 2024 | 199.48M |
May 20, 2024 | 203.30M |
May 17, 2024 | 249.14M |
May 16, 2024 | 294.98M |
May 15, 2024 | 249.14M |
May 14, 2024 | 260.60M |
May 13, 2024 | 260.60M |
May 10, 2024 | 199.48M |
May 09, 2024 | 230.04M |
May 08, 2024 | 126.89M |
May 07, 2024 | 149.82M |
May 06, 2024 | 153.64M |
May 03, 2024 | 165.10M |
May 02, 2024 | 157.46M |
May 01, 2024 | 176.56M |
April 30, 2024 | 264.42M |
April 29, 2024 | 115.43M |
April 26, 2024 | 130.72M |
Date | Value |
---|---|
April 25, 2024 | 96.33M |
April 24, 2024 | 88.69M |
April 23, 2024 | 84.87M |
April 22, 2024 | 42.85M |
April 19, 2024 | 46.67M |
April 18, 2024 | 61.95M |
April 17, 2024 | 65.77M |
April 16, 2024 | 73.41M |
April 15, 2024 | 73.41M |
April 12, 2024 | 100.15M |
April 11, 2024 | 111.61M |
April 10, 2024 | 138.36M |
April 09, 2024 | 161.28M |
April 08, 2024 | 172.74M |
April 05, 2024 | 165.10M |
April 04, 2024 | 191.84M |
April 03, 2024 | 241.50M |
April 02, 2024 | 153.64M |
April 01, 2024 | 149.82M |
March 31, 2024 | 138.36M |
March 28, 2024 | 130.22M |
March 27, 2024 | 164.53M |
March 26, 2024 | 141.65M |
March 25, 2024 | 84.46M |
March 22, 2024 | 130.22M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-203.72M
Minimum
Aug 15 2023
4.309B
Maximum
Feb 10 2021
778.70M
Average
488.11M
Median
Enterprise Value Benchmarks
Tilray Brands Inc | 1.648B |
Clever Leaves Holdings Inc | 0.0024M |
Flora Growth Corp | 13.89M |
Acasti Pharma Inc | 0.5379M |
Aurinia Pharmaceuticals Inc | 424.68M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -2.241M |
Revenue (Quarterly) | 25.29M |
Total Expenses (Quarterly) | 39.18M |
EPS Diluted (Quarterly) | -0.01 |
Gross Profit Margin (Quarterly) | 17.73% |
Profit Margin (Quarterly) | -8.86% |
Earnings Yield | -5.57% |
Normalized Earnings Yield | -0.891 |